CRISPR/Cas9 technology for targeted genome editing

von Lomov, N.A., Borunova, V.V., Rubtsov, M.A.
Veröffentlicht 2015

Treatment of lymphoid cells with the topoisomerase II poison etoposide leads to an increased juxtaposition of AML1 and ETO genes on the surface of nucleoli

von Rubtsov, M.A., Glukhov, S.I., Allinne, J., Pichugin, A., Vassetzky, Y.S., Razin, S.V., Iarovaia, O.V.
Veröffentlicht 2011